亚太地区益生菌婴幼儿配方奶粉市场预测至 2028 年 - COVID-19 影响和按类型(婴儿配方奶粉(0-1 岁)和成长配方奶粉(1-6 岁))和分销渠道(在线、和离线)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 77    |    Report Code: BMIRE00027446    |    Category: Consumer Goods

Asia Pacific Probiotic Infant and Child Formula Market

亚太地区益生菌婴幼儿配方奶粉预计将从2022年的91.7581亿美元增长到2028年的205.4846亿美元。预计从2022年起复合年增长率为14.4%到 2028 年。

有机婴儿配方奶粉的需求不断增长

近年来,婴儿配方奶粉市场对天然或有机产品的需求不断增长。父母的对婴儿有机营养和环境可持续性的兴趣预计将增加对有机婴儿配方奶粉的需求。益生菌配方中添加的有机成分解决了父母的问题。对产品安全和环境可持续性的担忧。各个品牌都在宣传“天然主张”。以获得市场的有机地位。亚太地区益生菌婴儿和儿童配方奶粉市场上的较大品牌已开始接受有机和可持续的信息,从而促进了有机婴儿配方奶粉产品的发展。例如,HiPP国际公司开发了一种有机婴儿配方奶粉,其中含有益生元、益生菌和其他最优质的有机成分,为婴儿提供所有营养。同样,Wellements 提供有机益生菌滴剂,支持儿童的消化和免疫健康。因此,有机婴儿配方奶粉消费的日益增长预计将为亚太地区益生菌婴儿和儿童配方奶粉市场提供增长机会。

市场概览  ;

亚太地区拥有世界60%的人口,近43亿人口,其中包括世界上人口最多的国家中国和印度。由于新妈妈们在儿童营养食品上的支出增加以及该地区人们的购买能力不断增强,预计该地区在预测期内将出现显着增长。根据世界银行 2020 年的报告,印度和中国的每名女性生育人数高于其他国家。预计这将增加预测期内亚太地区对益生菌婴儿和儿童配方奶粉的需求。

2028 年亚太地区益生菌婴幼儿配方奶粉市场收入及预测(百万美元)

亚太地区益生菌婴幼儿配方奶粉市场细分

< p>亚太地区益生菌婴幼儿配方奶粉市场按类型、分销渠道和国家/地区进行细分。

根据类型,将市场细分为婴儿配方奶粉(0-1岁)和成长配方奶粉(1-6岁)。成长配方奶粉(1-6岁)细分市场在2022年占据了较大的市场份额。根据分销渠道,市场分为线上和线下。 2022 年,线下细分市场占据更大的市场份额。根据国家/地区,市场分为澳大利亚、中国、日本、新西兰和亚太其他地区。 2022年,中国占据市场份额主导地位。 SA ; HiPP 有限公司Vertrieb KG 公司;雅培实验室和美赞臣公司公司、有限责任公司;和 Bellamy\'s Organic 是该地区益生菌婴儿和儿童配方奶粉领域的领先公司。



Asia Pacific Probiotic Infant and Child Formula Strategic Insights

Strategic insights for Asia Pacific Probiotic Infant and Child Formula involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-probiotic-infant-and-child-formula-market-strategic-framework.webp
Get more information on this report

Asia Pacific Probiotic Infant and Child Formula Report Scope

Report Attribute Details
Market size in 2022 US$ 9,175.81 Million
Market Size by 2028 US$ 20,548.46 Million
Global CAGR (2022 - 2028) 14.4%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 婴儿配方奶粉
  • 成长配方奶粉
By 分销渠道
  • 线上
  • 线下
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Nestlé S.A.
  • HiPP GmbH & Company Vertrieb KG
  • Abbott Laboratories
  • Mead Johnson & Company, LLC
  • Bellamys Organic
  • Get more information on this report

    Asia Pacific Probiotic Infant and Child Formula Regional Insights

    The regional scope of Asia Pacific Probiotic Infant and Child Formula refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-probiotic-infant-and-child-formula-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Probiotic Infant and Child Formula Market

    1. Nestlé S.A.                                                                         
    2. HiPP GmbH & Company Vertrieb KG                                      
    3. Abbott Laboratories                                                                      
    4. Mead Johnson & Company, LLC     
    5. Bellamy's Organic           
    Frequently Asked Questions
    How big is the Asia Pacific Probiotic Infant and Child Formula Market?

    The Asia Pacific Probiotic Infant and Child Formula Market is valued at US$ 9,175.81 Million in 2022, it is projected to reach US$ 20,548.46 Million by 2028.

    What is the CAGR for Asia Pacific Probiotic Infant and Child Formula Market by (2022 - 2028)?

    As per our report Asia Pacific Probiotic Infant and Child Formula Market, the market size is valued at US$ 9,175.81 Million in 2022, projecting it to reach US$ 20,548.46 Million by 2028. This translates to a CAGR of approximately 14.4% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Probiotic Infant and Child Formula Market report typically cover these key segments-

  • 类型 (婴儿配方奶粉, 成长配方奶粉)
  • 分销渠道 (线上, 线下)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Probiotic Infant and Child Formula Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Probiotic Infant and Child Formula Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific Probiotic Infant and Child Formula Market?

    The Asia Pacific Probiotic Infant and Child Formula Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Nestlé S.A.
  • HiPP GmbH & Company Vertrieb KG
  • Abbott Laboratories
  • Mead Johnson & Company, LLC
  • Bellamys Organic
  • Who should buy this report?

    The Asia Pacific Probiotic Infant and Child Formula Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Probiotic Infant and Child Formula Market value chain can benefit from the information contained in a comprehensive market report.